LITHIUM SECONDARY BATTERY WITH IMPROVED CELL CHARACTERISTICS
    2.
    发明申请
    LITHIUM SECONDARY BATTERY WITH IMPROVED CELL CHARACTERISTICS 有权
    锂二次电池具有改进的电池特性

    公开(公告)号:US20100297510A1

    公开(公告)日:2010-11-25

    申请号:US12723119

    申请日:2010-03-12

    IPC分类号: H01M6/16 H01M4/52

    摘要: Disclosed herein is a lithium secondary cell including 20 to 100 wt. % of lithium transition metal oxide represented by a formula of Li1+zNibMncMe1−(b+c)O2, relative to a total amount of a cathode active material, as well as an electrolyte consisting of a lithium salt and a non-aqueous solvent, wherein a first additive to form a protective film (that is, a solid electrolyte interface film: SEI film) over a surface of an anode active material and a second additive to form another SEI film over the surface of the anode active material while inactivating impurities contained in the cathode active material are included in the electrolyte.

    摘要翻译: 本文公开了一种锂二次电池,其包含20至100重量% 由Li1 + zNibMncMe1(b + c)O2表示的锂过渡金属氧化物的相对于阴极活性物质的总量以及由锂盐和非水溶剂组成的电解质的% 其中在阳极活性材料的表面上形成保护膜(即,固体电解质界面膜:SEI膜)的第一添加剂和第二添加剂,以在阳极活性材料的表面上形成另一SEI膜,同时使杂质失活 包含在阴极活性材料中的电解质包含在电解质中。

    MOBILE TERMINAL
    5.
    发明申请
    MOBILE TERMINAL 有权
    移动终端

    公开(公告)号:US20120309464A1

    公开(公告)日:2012-12-06

    申请号:US13241161

    申请日:2011-09-22

    IPC分类号: H04W88/02

    摘要: A mobile terminal and a method of controlling the mobile terminal are disclosed. In the mobile terminal, at least one second application executable in a second operating system different from a first operating system can be searched and provided among at least one first application executable in the first operating system. Accordingly, it is possible to provide a user interface for efficiently managing applications so as to be appropriate for various operating systems.

    摘要翻译: 公开了一种移动终端和控制移动终端的方法。 在移动终端中,可在第一操作系统中可执行的至少一个第一应用程序中搜索并提供在与第一操作系统不同的第二操作系统中可执行的至少一个第二应用程序。 因此,可以提供用于有效地管理应用程序的用户界面,以适合各种操作系统。

    PROCESS FOR OPTIMIZING THE PARTICLE SIZE OF AN ACTIVE PHARMACEUTICAL INGREDIENT BY CRYSTALLIZATION
    6.
    发明申请
    PROCESS FOR OPTIMIZING THE PARTICLE SIZE OF AN ACTIVE PHARMACEUTICAL INGREDIENT BY CRYSTALLIZATION 有权
    通过结晶优化活性药物成分颗粒尺寸的方法

    公开(公告)号:US20100311978A1

    公开(公告)日:2010-12-09

    申请号:US12788562

    申请日:2010-05-27

    申请人: Soojin KIM

    发明人: Soojin KIM

    IPC分类号: C07D471/04

    CPC分类号: C07D471/04

    摘要: A process to crystallize uniform small particles of a compound of Formula (I) with narrow particle size distribution and excellent powder characteristics that facilitate the formulation process and optimal drug product performance, wherein the compound of Formula (I) is: wherein R1, R2, and R3 are as described herein.

    摘要翻译: 使具有窄粒度分布和促进配制过程和最佳药物产品性能的优异粉末特性的式(I)化合物的均匀小颗粒结晶的方法,其中式(I)化合物为:其中R1,R2, 和R3如本文所述。